Mucinous adenocarcinoma of the appendix (MAA) is recognised as a biologically and histologically distinct entity from colorectal cancer and from colonic-type adenocarcinoma of the appendix. Its management is guided by histologic type and the extent of disease at presentation.
This protocol applies to patients with mucinous adenocarcinoma of the appendix — a subtype that requires a management approach distinct from that used for conventional colorectal adenocarcinoma. Clinical decision-making is based on histologic classification and stage at presentation.
The evidence-based approach for this scenario involves a surgical intervention whose indication is determined by pathologic findings and disease stage. The full decision criteria, procedural details, and any additional management steps are contained in the complete protocol.
DOI: 10.1055/s-0035-1564433